Header Logo

Connection

FIDA BACHA to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications FIDA BACHA has written about Diabetes Mellitus, Type 2.
FIDA BACHA
Connection Strength
8.125
Diabetes Mellitus, Type 2
  1. Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024 Dec 01; 47(12):2038-2049.
    View in: PubMed
    Score: 0.471
  2. Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
    View in: PubMed
    Score: 0.450
  3. Hyperglycemia: A determinant of cardiac autonomic dysfunction in youth with obesity across the spectrum of glycemic regulation. Pediatr Obes. 2023 10; 18(10):e13063.
    View in: PubMed
    Score: 0.425
  4. Candidate biomarkers as predictors of future kidney disease and cardiovascular dysfunction in adolescents with type 2 diabetes. Diabetes Res Clin Pract. 2023 May; 199:110671.
    View in: PubMed
    Score: 0.421
  5. Decline Pattern of Beta Cell Function in LADA: Relationship to GAD Autoantibodies. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.349
  6. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial. Pediatr Diabetes. 2019 11; 20(7):871-879.
    View in: PubMed
    Score: 0.327
  7. FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.
    View in: PubMed
    Score: 0.325
  8. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Horm Res Paediatr. 2018; 89(1):47-55.
    View in: PubMed
    Score: 0.288
  9. Endothelial Function in Youth: A Biomarker Modulated by Adiposity-Related Insulin Resistance. J Pediatr. 2016 Nov; 178:171-177.
    View in: PubMed
    Score: 0.265
  10. Relationship of Cardiac Structure and Function to Cardiorespiratory Fitness and Lean Body Mass in Adolescents and Young Adults with Type 2 Diabetes. J Pediatr. 2016 10; 177:159-166.e1.
    View in: PubMed
    Score: 0.265
  11. Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes. Curr Diab Rep. 2016 07; 16(7):62.
    View in: PubMed
    Score: 0.263
  12. Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants? Diabetes Care. 2014 Sep; 37(9):2632-9.
    View in: PubMed
    Score: 0.231
  13. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J Pediatr. 2013 May; 162(5):924-9.
    View in: PubMed
    Score: 0.206
  14. Progressive deterioration of ?-cell function in?obese youth with type 2 diabetes. Pediatr Diabetes. 2013 Mar; 14(2):106-11.
    View in: PubMed
    Score: 0.201
  15. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012 Aug; 13(5):376-83.
    View in: PubMed
    Score: 0.194
  16. Type 2 diabetes in youth: are there racial differences in ?-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes. 2012 May; 13(3):259-65.
    View in: PubMed
    Score: 0.189
  17. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010 Oct; 33(10):2225-31.
    View in: PubMed
    Score: 0.173
  18. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care. 2009 Jan; 32(1):100-5.
    View in: PubMed
    Score: 0.154
  19. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2017 08; 12(4):337-345.
    View in: PubMed
    Score: 0.130
  20. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes. Diabetes Care. 2015 Dec; 38(12):2285-92.
    View in: PubMed
    Score: 0.126
  21. Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial. Obesity (Silver Spring). 2015 Jul; 23(7):1357-61.
    View in: PubMed
    Score: 0.122
  22. Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
    View in: PubMed
    Score: 0.118
  23. The association of self-reported sleep and circadian measures with glycemic control and diabetes complications among young adults with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2024 06 01; 326(6):H1386-H1395.
    View in: PubMed
    Score: 0.113
  24. Relationship between Arterial Stiffness and Subsequent Cardiac Structure and Function in Young Adults with Youth-Onset Type 2 Diabetes: Results from the TODAY Study. J Am Soc Echocardiogr. 2022 06; 35(6):620-628.e4.
    View in: PubMed
    Score: 0.097
  25. Longitudinal changes in vascular stiffness and heart rate variability among young adults with youth-onset type 2 diabetes: results from the follow-up observational treatment options for type 2 diabetes in adolescents and youth (TODAY) study. Acta Diabetol. 2022 Feb; 59(2):197-205.
    View in: PubMed
    Score: 0.094
  26. Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
    View in: PubMed
    Score: 0.094
  27. Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021 07 29; 385(5):416-426.
    View in: PubMed
    Score: 0.093
  28. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.093
  29. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight. 2021 02 22; 6(4).
    View in: PubMed
    Score: 0.091
  30. ?-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum. Metabolism. 2020 11; 112:154346.
    View in: PubMed
    Score: 0.088
  31. Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study. Pediatr Diabetes. 2020 09; 21(6):923-931.
    View in: PubMed
    Score: 0.087
  32. Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 11; 42(11):2143-2150.
    View in: PubMed
    Score: 0.082
  33. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
    View in: PubMed
    Score: 0.078
  34. Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatr Diabetes. 2018 12; 19(8):1379-1384.
    View in: PubMed
    Score: 0.077
  35. Prevalence of arterial stiffness in adolescents with type 2 diabetes in the TODAY cohort: Relationships to glycemic control and other risk factors. J Diabetes Complications. 2018 Aug; 32(8):740-745.
    View in: PubMed
    Score: 0.075
  36. Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes. J Pediatr. 2018 05; 196:208-216.e2.
    View in: PubMed
    Score: 0.073
  37. Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr. 2018 01; 192:86-92.e5.
    View in: PubMed
    Score: 0.073
  38. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical?Trial. Am J Kidney Dis. 2018 01; 71(1):65-74.
    View in: PubMed
    Score: 0.072
  39. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off? Pediatr Diabetes. 2018 03; 19(2):205-211.
    View in: PubMed
    Score: 0.071
  40. Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care. 2017 Jan; 40(1):85-93.
    View in: PubMed
    Score: 0.067
  41. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes Care. 2016 Aug; 39(8):1431-9.
    View in: PubMed
    Score: 0.065
  42. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 05; 18(3):222-229.
    View in: PubMed
    Score: 0.064
  43. Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience. Diabetes Care. 2016 Jan; 39(1):122-9.
    View in: PubMed
    Score: 0.063
  44. Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Pediatr Diabetes. 2016 12; 17(8):584-591.
    View in: PubMed
    Score: 0.063
  45. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.063
  46. ?-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes. 2014 Nov; 63(11):3846-55.
    View in: PubMed
    Score: 0.057
  47. Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial. Pediatr Diabetes. 2015 Feb; 16(1):39-47.
    View in: PubMed
    Score: 0.055
  48. 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care. 2013 Jul; 36(7):2048-53.
    View in: PubMed
    Score: 0.052
  49. Metabolomic profiling of amino acids and ?-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012 Nov; 97(11):E2119-24.
    View in: PubMed
    Score: 0.050
  50. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012 Mar; 35(3):605-11.
    View in: PubMed
    Score: 0.048
  51. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011 Jul; 96(7):2136-45.
    View in: PubMed
    Score: 0.046
  52. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care. 2010 Mar; 33(3):632-8.
    View in: PubMed
    Score: 0.042
  53. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009 Mar; 58(3):738-44.
    View in: PubMed
    Score: 0.039
  54. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care. 2006 Jul; 29(7):1599-604.
    View in: PubMed
    Score: 0.033
  55. Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am. 2005 Dec; 52(6):1579-609.
    View in: PubMed
    Score: 0.032
  56. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care. 2005 Mar; 28(3):638-44.
    View in: PubMed
    Score: 0.030
  57. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care. 2005 Jan; 28(1):115-9.
    View in: PubMed
    Score: 0.030
  58. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003 Jun; 88(6):2534-40.
    View in: PubMed
    Score: 0.027
  59. ?-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak. Pediatr Diabetes. 2020 02; 21(1):18-27.
    View in: PubMed
    Score: 0.021
  60. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care. 2019 01; 42(1):164-172.
    View in: PubMed
    Score: 0.019
  61. Differences in ?-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role? Pediatr Diabetes. 2017 03; 18(2):143-151.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.